Business
Press Release Oct 29 2021
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding a press release dated October 29, 2021, titled "Balaxi Pharmaceuticals reports 19% PAT growth YoY for Q2FY22, lays down strategy of backward integration to have a sustainable growth in frontiermarkets".
About this update from Balaxi Pharmaceuticals Limited
[{"type":"text","content":" BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding a press release dated October 29, 2021, titled \"Balaxi Pharmaceuticals reports 19% PAT growth YoY for Q2FY22, lays down strategy of backward integration to have a sustainable growth in frontiermarkets\". View Attachment","length":429,"tagName":"div"}]